agilon health (NYSE:AGL) Given Hold Rating at Needham & Company LLC

Needham & Company LLC restated their hold rating on shares of agilon health (NYSE:AGL) in a research report sent to investors on Friday,Benzinga reports.

AGL has been the subject of a number of other reports. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and raised their price target for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Stifel Nicolaus boosted their target price on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Royal Bank of Canada upped their price target on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Sanford C. Bernstein raised their price objective on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Finally, Macquarie started coverage on agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, agilon health currently has a consensus rating of “Hold” and a consensus price target of $3.95.

agilon health Stock Performance

Shares of AGL stock opened at $4.51 on Friday. The firm has a 50 day moving average of $3.51 and a 200-day moving average of $2.95. The company has a market cap of $1.86 billion, a price-to-earnings ratio of -4.80 and a beta of 0.67. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73.

Institutional Investors Weigh In On agilon health

Several institutional investors and hedge funds have recently added to or reduced their stakes in AGL. JPMorgan Chase & Co. grew its holdings in shares of agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after acquiring an additional 1,083,492 shares in the last quarter. Inspire Investing LLC grew its stake in agilon health by 106.6% in the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after purchasing an additional 112,241 shares during the period. Citigroup Inc. increased its position in shares of agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after purchasing an additional 84,889 shares during the period. Finally, Empowered Funds LLC purchased a new position in shares of agilon health in the 4th quarter worth about $97,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.